Quality of Life following Adherence Therapy for People Disabled by Schizophrenia and their Carers

King's College London (UK)0 个研究点目标入组 400 人开始时间: 2003年5月19日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. International Statistical Classification of Diseases and Related Health Problems, Tenth edition (ICD-10) schizophrenia
•2. In the judgement of the responsible clinician are in need of maintenance anti-psychotic treatment for at least a year after entry to the study
•3. Clear evidence of clinical instability in the previous year, defined by one or more of the following:
•a. Hospital admission on clinical (mental health) grounds
•b. A change in anti-psychotic medication
•c. Increased frequency of contact (planned or actual)
•d. Indications of clinical instability from relatives or carers
•e. Indications of clinical instability from clinical team

•1. Patients suffering from moderate or severe learning disabilities concurrent with schizophrenia
•2. Patients suffering from organic brain disorders
•3. Patients being treated by forensic psychiatric services
•4. Dependence on alcohol or illicit substances
•5. Unable to speak language of host country to a sufficient standard to receive intervention
•6. Involved in other studies which are agreed locally to preclude inclusion
•7. Lack of capacity to consent to inclusion

发起方

King's College London (UK)